BDBM511745 (1R,3S,5R)-2-(2-(3-acetyl-7-methyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-N-((R)-1-((R)-2,2- dichlorocyclopropyl)ethyl)-5-methyl-2- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 52::US11708351, Compound 52

SMILES C[C@@H](NC(=O)[C@@H]1C[C@@]2(C)C[C@H]2N1C(=O)Cn1nc(C(C)=O)c2cc(cc(C)c12)-c1cnc(C)nc1)[C@H]1CC1(Cl)Cl

InChI Key InChIKey=LTMNFUPXIREIKO-SZIFNHHISA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 511745   

TargetComplement factor D(Homo sapiens (Human))
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM511745((1R,3S,5R)-2-(2-(3-acetyl-7-methyl-5-(2- methylpyr...)
Affinity DataIC50: <1.00E+3nMAssay Description:Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetComplement factor D(Homo sapiens (Human))
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM511745((1R,3S,5R)-2-(2-(3-acetyl-7-methyl-5-(2- methylpyr...)
Affinity DataIC50: <1.00E+3nMAssay Description:Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent